Here are the top news, trends, and analysis investors need to get their trading day started:
Senate Majority Leader Mitch McConnell (R-KY) speaks with fellow Senate Republicans at a news conference at the U.S. Capitol in Washington, DC on December 15, 2020.
Tom Brenner-Pool / Getty Images
Majority leader Mitch McConnell on Tuesday blocked efforts by minority leader Chuck Schumer to unanimously approve a parliament-passed bill to increase direct payments in the coronavirus aid package from $ 600 to $ 2,000.
The Kentucky Republican then introduced a new bill linking the increase with the repeal of Section 230 of the Communications Decency Act. The law would meet all of President Donald Trump’s recent demands that have nothing to do with one another but that would not receive democratic support and would become law.
An ambulance crew waits with a patient outside the Coast Plaza Hospital emergency room during a surge in coronavirus disease (COVID-19) cases in Los Angeles, California on December 26, 2020.
David Swanson | Reuters
The first case of a new Covid-19 strain has been confirmed in the United States, Colorado health officials said Tuesday.
The infected person, a man in his twenties, has no travel history and is in isolation in Elbert County, about an hour and a half south of Denver. Preliminary analysis of the mutant strain, first identified in the UK, suggests it could be up to 70% more transmissible.
studioEAST | Getty Images
Traders work on the trading floor of the New York Stock Exchange.
NYSE
US stock futures rose Wednesday morning as the market tried to recover from a slight decline in the previous session and added to its already strong 2020 performance. The Dow Jones Industrial Average futures rose 73 points, or 0.2%. The futures on S&P 500 and Nasdaq 100 gained 0.4% each.
At the start of the session, the Dow and S&P 500 were up 6.3% and 15.4%, respectively, over the year. The Nasdaq Composite is up more than 40% since the beginning of the year.
CSL staff will be working in the laboratory in Melbourne, Australia on November 8th. CSL will start manufacturing the AstraZeneca-Oxford University’s Covid-19 vaccine from Monday.
Darrian Traynor | Getty Images News | Getty Images
A coronavirus vaccine developed by Oxford University and AstraZeneca was approved for emergency use in the UK on Wednesday. The vaccine is expected to be launched next week. Unlike vaccines developed by Pfizer and Moderna, it does not need to be stored at extremely low temperatures.
AstraZeneca said in a statement that it “plans to ship millions of cans in the first quarter” as part of its agreement with the UK government to provide up to 100 million cans in total.
– Follow all developments on Wall Street in real time with CNBC Pro’s live market blog. Find out about the latest pandemics on our coronavirus blog.
Shares of Eli Lilly fell 6% on Tuesday and are on track for their worst…
The White House described Trump's press conference with Vice President JD Vance as evidence that…
The 2026 Oscars may be over, but film's biggest night continues. After One Battle After…
Defense Secretary Pete Hegseth brushed aside concerns Friday that the actual closure of the Strait…
Eine neue Analyse der US-Volkszählungsdaten zeigt, dass Bundesstaaten in den USA, in denen in diesem…
A sign hangs in front of the world headquarters of Vertex Pharmaceuticals in Boston.Brian Snyder…
This website uses cookies.